Among The Toughest Cancers To Treat, New ABRAXANE(R) Data Demonstrates Potential In Patients With Advanced And Malignant Melanoma

Links shared publicly online about this topic.

  • 1,105
    total visits

Among The Toughest Cancers To Treat, New ABRAXANE(R) Data Demonstrates Potential In Patients With Advanced And Malignant Melanoma

medicalnewstoday.com —

Abraxis BioScience, Inc. (NASDAQ:ABII) presented trial design information from its ongoing phase 3 registration trial of nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (

View full resource at medicalnewstoday.com

Tags: Cancer, Chemotherapy, Skin Cancer, Melanoma

  • Share

Most Recently Shared on June 10, 2010 at 7:40 pm By:

SkinCancer_OW Skin Cancer OW

Among The Toughest Cancers To Treat, New ABRAXANE(R) Data Demonstrates Potential In Patients With Advanced And Mal... http://bit.ly/aO6xub

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Skin Cancer MNT Skin Cancer

Advertisement